|
Volumn 50, Issue 11, 1997, Pages 862-870
|
Efficacy and safety of sulbactum/cefoperazone for hepato-biliary infections
a a a a a a a a a a a a a a a a a a a a more.. |
Author keywords
[No Author keywords available]
|
Indexed keywords
CEFOPERAZONE;
SULBACTAM;
SULPERAZONE;
ANTIBIOTIC THERAPY;
ARTICLE;
CHOLANGITIS;
CHOLECYSTITIS;
DRUG HYPERSENSITIVITY;
ENTEROBACTER INFECTION;
ENTEROCOCCUS;
ESCHERICHIA COLI;
GRAM NEGATIVE INFECTION;
HUMAN;
LIVER ABSCESS;
MAJOR CLINICAL STUDY;
PSEUDOMONAS AERUGINOSA;
RASH;
ADOLESCENT;
ADULT;
AGED;
CLINICAL TRIAL;
DRUG COMBINATION;
FEMALE;
MALE;
MIDDLE AGED;
MULTICENTER STUDY;
NEOPLASM;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
CEFOPERAZONE;
CHOLANGITIS;
CHOLECYSTITIS;
DRUG COMBINATIONS;
ENTEROCOCCUS;
FEMALE;
HUMANS;
KLEBSIELLA INFECTIONS;
LIVER ABSCESS;
MALE;
MIDDLE AGED;
NEOPLASMS;
PSEUDOMONAS INFECTIONS;
SULBACTAM;
TREATMENT OUTCOME;
|
EID: 0031283496
PISSN: 03682781
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (10)
|
References (12)
|